|
EI 2680-9601 A
|
Adenovirus
|
IgA
|
|
semi-quantitative
|
96 x 01
|
|
EI 2680-9601 G
|
Adenovirus
|
IgG
|
|
2/20/200 RU/ml
|
96 x 01
|
|
EI 2680-9601 M
|
Adenovirus
incl. IgG/RF absorbent
|
IgM
|
|
semi-quantitative
|
96 x 01
|
|
FI 2680-1005 A
FI 2680-1005 G
FI 2680-1005 M
|
Adenovirus
type 3
|
IgA
IgG
IgM
|
infected cells
|
EU 38
|
10 x 05 (test system)
10 x 05 (test system)
10 x 05 (test system)
|
|
FI 2821-1001-1 G
FI 2821-1002-1 G
FI 2821-2002-1 G
FI 2821-1001-1 M
FI 2821-1002-1 M
FI 2821-2002-1 M
|
Respiratory Tract Profile 1
(consisting of 21 different substrates)
|
IgG
IgM
|
field A: verification BIOCHIP, RSV,
Adenovirus type 3, Influenza virus
type A (H1N1 and H3N2)
field B: Influenza virus type B,
Parainfluenza virus type 1, 2, 3
field C: Parainfluenza virus type 4,Bordetella pertussis and parapertussis,
Mycoplasma pneumoniae
field D: Coxsackie virus type B1 and
A7, Echo virus type 7, Chlamydia
pneumoniae
field E: Haemophilus influenzae*,
Klebsiella pneumoniae*, Legionella
pneumophila serotype 1 and 12
|
|
10 x 01 (test system)
10 x 02 (test system)
20 x 02 (test system)
10 x 01 (test system)
10 x 02 (test system)
20 x 02 (test system)
|
|
FI 2823-1001-1 G *
FI 2823-1002-1 G *
FI 2823-1001-1 M *
FI 2823-1002-1 M *
|
Lymphadenitis Profile 1
(consisting of 21 different substrates)
|
IgG
IgM
|
field A: verification BIOCHIP, HIV-1*
and 2*, HHV-6, Rubella virus*
field B: measles virus, Mumps virus,
Adenovirus type 3,
Parainfluenza virus type 1
field C: EBV-CA, EBV-EA, Toxoplasma
gondii, Treponema pallidum
field D: HSV-1 and -2, CMV,
Coxsackie virus type B5
field E: Coxsackie virus type A9,
Bartonella henselae, Chlamydia
trachomatis and pneumoniae
|
|
10 x 01 (test system)
10 x 02 (test system)
10 x 01 (test system)
10 x 02 (test system)
|
|
FI 2824-1001-1 G
FI 2824-1002-1 G
FI 2824-1001-1 M *
FI 2824-1002-1 M *
|
Central Nervous System Profile 1
(consisting of 21 different substrates)
|
IgG
IgM
|
field A: verification BIOCHIP,
Rubella virus*, Measles virus,
Mumps virus, VZV
field B: Adenovirus type 3, EBV-CA,
Treponema pallidum,
Toxoplasma gondii
field C: HSV-1 and -2, Coxsackie virus
type B1 and A7
field D: Echo virus type 7, Borrelia afzelii,
burgdorferi (CH), garinii
field E: CMV, Haemophilus influenzae*,
Listeria monocytogenes 1/2a und 4b
|
|
10 x 01 (test system)
10 x 02 (test system)
10 x 01 (test system)
10 x 02 (test system)
|
|
FI 2825-1001-1 G
FI 2825-1002-1 G
FI 2825-1001-1 M
FI 2825-1002-1 M
|
Myocarditis Profile 1
(consisting of 17 different substrates)
|
IgG
IgM
|
field A: verification BIOCHIP, Mumps
virus, Adenovirus type 3, Influenza
virus type A (H1N1 and H3N2)
field B: Influenza virus Typ B,
Parainfluenza virus type 1 and 2,
Mycoplasma pneumoniae
field C: CMV, Coxsackie virus type B1
and A16, Echo virus type 7
field D: Borrelia afzelii, burgdorferi (CH),
garinii, Chlamydia pneumoniae
|
|
10 x 01 (test system)
10 x 02 (test system)
10 x 01 (test system)
10 x 02 (test system)
|
|
CI 2680-0101 A
|
antibodies against Adenovirus
IgA positive control
|
IgA
|
|
|
0.1 ml
|
|
CI 2680-0101 Z
|
Adenovirus
negative control
|
IgA, IgG, IgM
|
|
|
0.1 ml
|
|
CI 2680-0101 G
|
antibodies against Adenovirus
IgG positive control
|
IgG
|
|
|
0.1 ml
|
|
CI 2680-0101 M
|
antibodies against Adenovirus
IgM positive control
|
IgM
|
|
|
0.1 ml
|
